JP2013544244A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544244A5 JP2013544244A5 JP2013539093A JP2013539093A JP2013544244A5 JP 2013544244 A5 JP2013544244 A5 JP 2013544244A5 JP 2013539093 A JP2013539093 A JP 2013539093A JP 2013539093 A JP2013539093 A JP 2013539093A JP 2013544244 A5 JP2013544244 A5 JP 2013544244A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- interleukin
- inflammation
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 19
- 102000015696 Interleukins Human genes 0.000 claims 6
- 108010063738 Interleukins Proteins 0.000 claims 6
- 206010061218 Inflammation Diseases 0.000 claims 5
- 230000004054 inflammatory process Effects 0.000 claims 5
- 230000004968 inflammatory condition Effects 0.000 claims 4
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 102000000588 Interleukin-2 Human genes 0.000 claims 2
- 108010002350 Interleukin-2 Proteins 0.000 claims 2
- 230000002159 abnormal effect Effects 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 230000000172 allergic effect Effects 0.000 claims 2
- 206010003246 arthritis Diseases 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 210000004877 mucosa Anatomy 0.000 claims 2
- 239000007892 solid unit dosage form Substances 0.000 claims 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 claims 1
- 208000005171 Dysmenorrhea Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000021386 Sjogren Syndrome Diseases 0.000 claims 1
- 206010064921 Urinary tract inflammation Diseases 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000009890 sinusitis Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010551433.8 | 2010-11-19 | ||
| CN201010551433.8A CN102462837B (zh) | 2010-11-19 | 2010-11-19 | 抗炎组合物 |
| PCT/AU2011/001446 WO2012065212A1 (en) | 2010-11-19 | 2011-11-09 | Anti-inflammatory compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013544244A JP2013544244A (ja) | 2013-12-12 |
| JP2013544244A5 true JP2013544244A5 (cg-RX-API-DMAC7.html) | 2014-12-25 |
Family
ID=46067145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013539093A Pending JP2013544244A (ja) | 2010-11-19 | 2011-11-09 | 抗炎症組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9289493B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2640411B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2013544244A (cg-RX-API-DMAC7.html) |
| KR (1) | KR101989201B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102462837B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011331901B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2817996C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2640411T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX348794B (cg-RX-API-DMAC7.html) |
| MY (1) | MY174797A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2627451C9 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012065212A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9669071B2 (en) | 2011-03-11 | 2017-06-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for stimulating T lymphocytes with IL-2 |
| AU2012228418B2 (en) * | 2011-03-11 | 2016-09-29 | Assistance Publique - Hopitaux De Paris | Use of low dose IL-2 for treating autoimmune - related or inflammatory disorders |
| NL2009794C2 (nl) | 2012-11-13 | 2014-05-14 | Hevorma B V | Groei-inrichting voor gewas, gebruik van een dergelijke inrichting, en een reeks groei-inrichtingen. |
| EP3180020B1 (en) | 2014-08-11 | 2018-12-26 | Delinia, Inc. | Modified il-2 variants that selectively activate regulatory t cells for the treatment of autoimmune diseases |
| CA2977743C (en) * | 2015-02-25 | 2024-04-23 | Outsense Diagnostics Ltd. | Bodily emission analysis |
| US20170204154A1 (en) | 2016-01-20 | 2017-07-20 | Delinia, Inc. | Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases |
| BR112019004896A2 (pt) * | 2016-09-15 | 2019-06-04 | Skintech Life Science Ltd | administração sublingual ou bucal de dim para o tratamento de doenças da pele |
| US11077172B2 (en) | 2016-11-08 | 2021-08-03 | Delinia, Inc. | IL-2 variants for the treatment of psoriasis |
| PH12022550165A1 (en) | 2019-07-26 | 2023-05-08 | Visterra Inc | Interleukin-2 agents and uses thereof |
| CN115427437B (zh) * | 2020-03-31 | 2024-04-19 | 韩美药品株式会社 | 新型免疫刺激il-2类似物 |
| US12098178B2 (en) | 2020-12-04 | 2024-09-24 | Visterra, Inc. | Methods of using interleukin-2 agents |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH671155A5 (cg-RX-API-DMAC7.html) * | 1986-08-18 | 1989-08-15 | Clinical Technologies Ass | |
| ATE113469T1 (de) * | 1990-06-21 | 1994-11-15 | Edith Dr Huland | Verwendung zytokinhaltiger aerosole und zytokinhaltige aerosole selbst. |
| US6509313B1 (en) * | 1996-02-28 | 2003-01-21 | Cornell Research Foundation, Inc. | Stimulation of immune response with low doses of cytokines |
| US7361331B2 (en) | 1996-10-18 | 2008-04-22 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food | Plant bioreactors |
| JP4023863B2 (ja) | 1997-03-13 | 2007-12-19 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | Ｉｌ−６を含む血清尿酸値低下剤 |
| FR2769505B1 (fr) * | 1997-10-10 | 2000-06-30 | Michael Gerard Tovey | Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations |
| US6974590B2 (en) | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
| CA2356010A1 (en) * | 1998-12-22 | 2000-06-29 | Schering Corporation | Treatment of hepatitis c virus infections with interleukin-10 |
| DE60038304T3 (de) | 1999-09-09 | 2017-04-06 | Merck Sharp & Dohme Corp. | Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen |
| AUPR272901A0 (en) | 2001-01-25 | 2001-02-22 | Gainful Plan Limited | Method of preparing biological materials and preparations produced using same |
| EP1545474A1 (en) * | 2002-09-16 | 2005-06-29 | Wyeth | Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same |
| GB0501540D0 (en) * | 2005-01-25 | 2005-03-02 | Univ Leeds | Controlled production and delivery of biologically active agents by gut bacteria |
| AU2008226337B2 (en) * | 2007-03-14 | 2012-02-16 | BioLingus IP II GmbH | Method for treating cancer via the mucosal administration of interleukin |
| CN102174111B (zh) * | 2011-01-25 | 2013-01-09 | 江苏省弗泰生物科技有限公司 | 人白介素2-Fc融合蛋白及其用途 |
-
2010
- 2010-11-19 CN CN201010551433.8A patent/CN102462837B/zh active Active
-
2011
- 2011-11-09 EP EP11840904.4A patent/EP2640411B1/en not_active Not-in-force
- 2011-11-09 CA CA2817996A patent/CA2817996C/en active Active
- 2011-11-09 RU RU2013127793A patent/RU2627451C9/ru active
- 2011-11-09 MX MX2013005641A patent/MX348794B/es active IP Right Grant
- 2011-11-09 AU AU2011331901A patent/AU2011331901B2/en not_active Ceased
- 2011-11-09 JP JP2013539093A patent/JP2013544244A/ja active Pending
- 2011-11-09 KR KR1020137015896A patent/KR101989201B1/ko not_active Expired - Fee Related
- 2011-11-09 WO PCT/AU2011/001446 patent/WO2012065212A1/en not_active Ceased
- 2011-11-09 MY MYPI2013700815A patent/MY174797A/en unknown
- 2011-11-09 DK DK11840904.4T patent/DK2640411T3/en active
- 2011-11-09 US US13/885,993 patent/US9289493B2/en active Active - Reinstated
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544244A5 (cg-RX-API-DMAC7.html) | ||
| RU2013127793A (ru) | Противовоспалительные композиции | |
| Jacques et al. | The role of IL‐1 and IL‐1Ra in joint inflammation and cartilage degradation | |
| Kuo et al. | Prompt healing of erosive oral lichen planus lesion after combined corticosteroid treatment with locally injected triamcinolone acetonide plus oral prednisolone | |
| CN103429236B (zh) | 治疗高尿酸血症和与高尿酸血症相关的代谢性病症的方法和组合物 | |
| JP2016523862A5 (cg-RX-API-DMAC7.html) | ||
| EA201290171A1 (ru) | Вводимые перорально кортикостероидные композиции | |
| JP2015129189A5 (cg-RX-API-DMAC7.html) | ||
| JP2014526503A5 (cg-RX-API-DMAC7.html) | ||
| JP2016517888A5 (cg-RX-API-DMAC7.html) | ||
| Lee et al. | Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial | |
| AR095372A1 (es) | Terapia de inducción con rituximab seguida por una terapia con acetato de glatiramer | |
| JP2014523906A5 (cg-RX-API-DMAC7.html) | ||
| JP2010534236A5 (cg-RX-API-DMAC7.html) | ||
| JP2011157375A5 (cg-RX-API-DMAC7.html) | ||
| MA38169A1 (fr) | Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux | |
| JP2019527714A5 (cg-RX-API-DMAC7.html) | ||
| JP2010500284A5 (cg-RX-API-DMAC7.html) | ||
| JP2009502805A5 (cg-RX-API-DMAC7.html) | ||
| RU2014125519A (ru) | Ацил-гидразоновые и оксадиазоловые соединения, фармацевтические композиции, содержащие их, и их применение | |
| JP2008533079A5 (cg-RX-API-DMAC7.html) | ||
| CN103040805A (zh) | 辛夷脂素的医药用途 | |
| UY31363A1 (es) | Composiciones farmaceuticas que comprenden la combinacion de un agente antiflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas | |
| Weng et al. | The common link between sleep apnea syndrome and osteoarthritis: a literature review | |
| CN111315370A (zh) | 一种具有抗炎症性肠病作用的药物及其制备方法和应用 |